Moreover, our findings establish that WISP1 enhances metastatic plasticity in ER+ breast cancer by amplifying MIF signaling and engaging Lyn/Fyn-mediated cytoskeletal remodeling, even in low-CD74 contexts. Here, CD74 is linked to breast carcinoma.